SMARCC1 and autoimmune disease: Taken together, our results demonstrated that CD2-SRG3-overexpressing mice are much more vulnerable to the pathogenesis of autoimmune diseases such as EAE but that the over-expression of SRG3 in additional cell types inhibits EAE development.